Unicycive Therapeutics (UNCY)
Develops kidney-disease candidates for dialysis and acute injury.
$4.99
After-hours close+0.03 (+0.60%)
At close$4.96(+3.98%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 41.88% | 11.67M shares | |
|---|---|---|---|
| 90 holders · as of Jun 30, 2026 | |||
| Insiders | 6.43% | 1.79M shares | |
| 1 holder · as of Aug 26, 2025 | |||
| Strategic holders | 4.21% | 1.17M shares | |
| 1 holder · as of Jan 23, 2026 | |||
| Other | 47.48% | 13.23M shares | |
| remainder | |||
27.86M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
90 holders · 11.67M shares · 37 new positions · 61 increased · 10 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.41M | 5.07% | +1.38M | Aug 7, 2026 |
| Nantahala Capital Management, LLC | 1.40M | 5.03% | +462.2K | Aug 19, 2026 |
| Vanguard Capital Management LLC | 1.07M | 3.85% | +260.1K | Aug 13, 2026 |
| Octagon Capital Advisors LP | 1.00M | 3.59% | 0 | Aug 14, 2026 |
| Geode Capital Management, LLC | 564.0K | 2.02% | +360.3K | Aug 12, 2026 |
| Vivo Capital, LLC | 550.0K | 1.97% | −1.24M | Aug 14, 2026 |
| Marshall Wace, LLP | 547.9K | 1.97% | +392.9K | Aug 13, 2026 |
| Logos Global Management LP | 473.6K | 1.70% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 2.28M | 13G | Feb 13, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 6.10M | 13G | Nov 14, 2025 |
| Great Point Partners, LLC | 9.99% | 13G | Feb 14, 2025 | |
| RA Capital Management, L.P. | 9.90% | 2.80M | 13G | May 15, 2026 |
| Octagon Capital Advisors LPincl. Octagon Investments Master Fund LP, Octagon Private Opportunities Fund II LP +1 more | 9.10% | 13G | Oct 11, 2024 | |
| Biotechnology Value Fund L P | 5.70% | 777.3K | 13G | Aug 14, 2025 |
| Integrated Core Strategies (US) LLC | 5.50% | 1.17M | 13G | Jan 23, 2026 |
| BlackRock, Inc. | 5.30% | 1.41M | 13G | Jul 30, 2026 |
| Walleye Capital LLC | 5.30% | Nov 13, 2024 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.